Status:
RECRUITING
DIC Markers and Thrombin Generation Parameters in Patients on ECMO Support: a Pilot Study
Lead Sponsor:
Queen Mary Hospital, Hong Kong
Conditions:
Extracorporeal Circulation; Complications
Extracorporeal Membrane Oxygenation Complication
Eligibility:
All Genders
Up to 80 years
Brief Summary
To study the correlation between novel DIC markers and thrombin generation parameters with thrombotic and hemorrhagic complications of patients on ECMO support.
Eligibility Criteria
Inclusion
- Age ≧ 18; AND
- Admitted to the mixed medical-surgical intensive care units of Queen Mary Hospital or Tuen Mun Hospital in Hong Kong; AND
- Require either veno-arterial (VA) or veno-venous (VV) extracorporeal membrane oxygenation (ECMO) support.
Exclusion
- Patients who are on central VA-ECMO support; OR
- Patients with missing clinical data; OR
- Patients with pre-existing thromboembolism requiring long term anticoagulation prior to ECMO cannulation; OR
- Post-operative admissions
Key Trial Info
Start Date :
May 30 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06095518
Start Date
May 30 2023
End Date
December 31 2025
Last Update
July 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary Hospital
Hong Kong, Hong Kong